Alliancebernstein Trims Stake in Cooper Companies

Institutional investor reduces holdings in medical device company by 15.7%

Mar. 17, 2026 at 7:08am

Got story updates? Submit your updates here. ›

Alliancebernstein L.P., a major institutional investor, has reduced its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 15.7% during the third quarter, according to a recent SEC filing. The firm now owns approximately 3.19 million shares, or about 1.6% of the medical device company's outstanding stock.

Why it matters

Cooper Companies is a major player in the vision care and women's health products markets, so changes in institutional ownership can signal shifts in investor sentiment around the company's performance and future prospects.

The details

According to the 13F filing, Alliancebernstein sold 594,374 shares of Cooper Companies stock during the third quarter. The firm now holds 3,190,534 shares valued at around $218.7 million. Several other institutional investors also made changes to their Cooper Companies positions during the period, with some increasing and others decreasing their stakes.

  • Alliancebernstein reduced its Cooper Companies holdings during the third quarter of 2026.

The players

Alliancebernstein L.P.

A major institutional investor that manages over $700 billion in assets.

The Cooper Companies, Inc.

A global medical device company that develops, manufactures, and markets vision care and women's health products.

Got photos? Submit your photos here. ›

The takeaway

This filing indicates that one of Cooper Companies' largest institutional shareholders has reduced its position, which could signal a shift in investor sentiment around the company's outlook. However, the overall level of institutional ownership remains high, suggesting the company continues to be viewed favorably by the investment community.